Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.

Sandler, E; Lyden, E; Ruymann, F; Maurer, H; Wharam, M; Parham, D; Link, M; Crist, W

Sandler, E; Lyden, E; Ruymann, F; Maurer, H; Wharam, M; Parham, D; Link, M; Crist, W.

Affiliation

Sandler E; Intergroup Rhabdomyosarcoma Study Group Operations Office, Children's Oncology Group, Arcadia, CA 91066-6012, USA. smason@nccf.org

Med Pediatr Oncol ; 37(5): 442-8, 2001 Nov.

Article de En | MEDLINE | ID: mdl-11745872

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rhabdomyosarcome / Protocoles de polychimiothérapie antinéoplasique Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Langue: En Journal: Med Pediatr Oncol Année: 2001 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links